Exploratory Study to Evaluate the Efficacy and Safety of CD07223 Gel in Subjects With Acne

Exclusion Criteria

• •subject has a severe acne form or secondary acne form
• •the number of inflammatory or non-inflammatory lesions on one half-face is greater than twice the number on the other half-face
• •the subject has a known allergy or sensitivity to any of the components of the study products
• •subject is not willing to respect wash-out periods for topical and/or systemic treatments